You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

228 Results
Guidelines and Advice
Status: Current
ID: GL-C50-15
Jun 2014
Drug
Other Name(s): Suprefact® , Suprefact Depot® , Suprefact Nasal Spray®
Nov 2024
Drug
Other Name(s): Busulfex® , Myleran®
Jun 2019
Drug
Other Name(s): Casodex® (multiple brands available)
Apr 2024
Drug
Nov 2024
Drug
Other Name(s): Treanda®
Nov 2024
Drug
Other Name(s): Kadcyla®
Aug 2023
Drug
Other Name(s): Bosulif®
Nov 2024
Drug
Other Name(s): Blincyto®
Nov 2024
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019

Pages